Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EVAX
EVAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EVAX News
Evaxion Wins 2026 Prix Galien Award for AI-Immunology™
3d ago
Newsfilter
Evaxion's EVX-04 Vaccine Shows Promise Against AML in Preclinical Findings
4d ago
NASDAQ.COM
Evaxion's EVX-04 Vaccine Successfully Expressed in Human Cells for AML Treatment
4d ago
Newsfilter
Evaxion (EVAX) Q1 2026 Earnings Transcript
May 07 2026
NASDAQ.COM
Evaxion Biotech Reports Q1 2026 Financial Results
May 07 2026
seekingalpha
Evaxion Reports Promising Phase 2 Trial Results for Personalized Cancer Vaccine EVX-01
Apr 20 2026
NASDAQ.COM
EVX-01 Cancer Vaccine Data Shows Record Immune Response Rates
Apr 17 2026
Newsfilter
Evaxion A/S Holds Annual General Meeting Approving Key Proposals
Apr 16 2026
Newsfilter
Evaxion A/S Reports Strong Q4 2025 Earnings and Strategic Developments
Mar 06 2026
seekingalpha
Evaxion Biotech Reports FY EPS Beat Expectations
Mar 05 2026
seekingalpha
Evaxion A/S Provides 2025 Business and Financial Update
Mar 05 2026
Newsfilter
Evaxion to Report 2025 Financial Results on March 5
Mar 02 2026
Yahoo Finance
Evaxion Looks for New Partner for Gonorrhea Vaccine Following Merck's Withdrawal
Dec 19 2025
Benzinga
Evaxion Retains Global Rights to EVX-B2 After MSD Declines Option
Dec 19 2025
Globenewswire
Evaxion Retains Global Rights to EVX-B2 After MSD Declines Option
Dec 19 2025
Newsfilter
Evaxion Unveils EVX-04 Cancer Vaccine, Significantly Inhibiting Tumor Growth
Dec 06 2025
Globenewswire
Show More News
